Evidence also links the Hippo pathway to breast CSCs with YAP being overactivated in poorly differentiated breast cancers (G3) which are enriched in CSCs, compared with well-differentiated breast cancers (G1) [12]. This evidence concerns the gene YAP1 and breast cancer.